Government Memos on Ecstasy
Hallucinogens pose no greater risk than other investigational drugs, FDA’s Drug Abuse Advisory Committee agreed at its July 15 meeting.
Government Memos on Ecstasy is a report summarizing the committee’s findings on the level of harm caused by hallucinogens pose.
After being asked to assess problems that might be associated with allowing research to be conducted with hallucinogenic drugs.
FDA Pilot Drug Staff Medical Officer Curtis Wright, MD, said: “I have not heard any discussion of risks involving these compounds that we do not routinely face with every new drug we put through the IND process.”
A great read for anyone interested in hallucinogen’s and their adverse effects.
